Carolinas Wealth Consulting’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-49
Closed -$16.9K 394
2025
Q1
$16.9K Buy
49
+1
+2% +$322 ﹤0.01% 472
2024
Q4
$14.4K Sell
48
-7
-13% -$2.45K ﹤0.01% 508
2024
Q3
$22.4K Buy
55
+2
+4% +$732 ﹤0.01% 469
2024
Q2
$17K Hold
53
﹤0.01% 493
2024
Q1
$17.7K Buy
53
+1
+2% +$306 ﹤0.01% 490
2023
Q4
$14.1K Hold
52
﹤0.01% 496
2023
Q3
$11.8K Sell
52
-794
-94% -$217K ﹤0.01% 501
2023
Q2
$257K Sell
846
-64
-7% -$17.8K 0.05% 155
2023
Q1
$240K Buy
910
+1
+0.1% +$254 0.05% 155
2022
Q4
$218K Buy
909
+27
+3% +$6.05K 0.05% 155
2022
Q3
$162K Buy
882
+13
+1% +$2.59K 0.04% 171
2022
Q2
$146K Buy
869
+119
+16% +$25.6K 0.04% 191
2022
Q1
$188K Hold
750
0.04% 177
2021
Q4
$193K Hold
750
0.04% 172
2021
Q3
$182K Hold
750
0.04% 170
2021
Q2
$155K Sell
750
-289
-28% -$58.9K 0.03% 202
2021
Q1
$196K Hold
1,039
0.05% 165
2020
Q4
$171K Hold
1,039
0.05% 164
2020
Q3
$130K Hold
1,039
0.04% 166
2020
Q2
$101K Buy
+1,039
New +$108K 0.04% 148

Other funds holding HCA

Carolinas Wealth Consulting's HCA Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 49 shares — an estimated $16.9K sold.

Carolinas Wealth Consulting first reported a position in HCA in Q2 2020 and held it in 20 quarters. The position peaked at $257K in Q2 2023. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 49 HCA Healthcare shares in Q2 2025, an estimated $16.9K.
  • Carolinas Wealth Consulting first reported a position in HCA Healthcare in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's HCA Healthcare position peaked at $257K in Q2 2023.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.